4th Quarter - Report — SIEMENS MEDICAL SOLUTIONS USA, INC for SIEMENS MEDICAL SOLUTIONS USA, INC (2021)

Firm

SIEMENS MEDICAL SOLUTIONS USA, INC

Client

SIEMENS MEDICAL SOLUTIONS USA, INC

Income

—

Expenses

$260,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).

Lobbyist	Covered position, as disclosed
MARK ESHERICK	—
ELEANOR WENNER KERR	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Agriculture, Dept of (USDA); Justice, Dept of (DOJ); Commerce, Dept of (DOC)

Bills named: H.R. 4479 (117th), S. 2609 (117th)

Health Issues HCR

HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment; Copyright 1201 exemption impacting medical devices

Lobbyist	Covered position, as disclosed
MARK ESHERICK	—
ELEANOR WENNER KERR	—

Contacted: Food & Drug Administration (FDA); Justice, Dept of (DOJ); Agriculture, Dept of (USDA); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4128 (117th), H.R. 1319 (117th), S. 2209 (117th)

Trade (domestic/foreign) TRD

Export of raw materials to China.

Lobbyist	Covered position, as disclosed
MARK ESHERICK	—

Contacted: Food & Drug Administration (FDA); Justice, Dept of (DOJ); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.